Inventor · disambiguated record
Langdon Miller
Also filed as: MILLER LANGDON · MILLER LANGDON L
21 granted patents·20 pending applications·148 citations·filing 1999–2022
95Inventor score
Files withPTC THERAPEUTICS INC13CAO LIANGXIAN8GILEAD CALISTOGA LLC5ALMSTEAD NEIL2GALLATIN W MICHAEL2
Top patents by PatentIndex Score
41 records- 0193US8716321B2Methods for dosing an orally active 1,2,4-oxadiazoleHIRAWAT SAMIT·Filed 2006·Granted May 6, 2014·29 cites·31 claims
- 0293US8076352B2Administration of carboline derivatives useful in the treatment of cancer and other diseasesCAO LIANGXIAN·Filed 2007·Granted Dec 13, 2011·30 cites·18 claims
- 0391US9522137B2Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2015·Granted Dec 20, 2016·8 cites·10 claims
- 0490US9877952B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2017·Granted Jan 30, 2018·6 cites·9 claims
- 0590US9737513B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·6 cites·9 claims
- 0689US10034863B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·5 cites·8 claims
- 0789US9474743B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2014·Granted Oct 25, 2016·8 cites·15 claims
- 0888US10172836B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapyPTC THERAPEUTICS INC·Filed 2018·Granted Jan 8, 2019·4 cites·9 claims
- 0988US9226919B2Methods for dosing an orally active 1,2,4-oxadiazoleHIRAWAT SAMIT·Filed 2007·Granted Jan 5, 2016·10 cites·14 claims
- 1086US9289398B2Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewithALMSTEAD NEIL·Filed 2007·Granted Mar 22, 2016·9 cites·6 claims
- 1186US8703726B2Methods for treating prostate conditionsCAO LIANGXIAN·Filed 2010·Granted Apr 22, 2014·6 cites·15 claims
- 1285US8697662B2Methods for treating Kaposi sarcomaCAO LIANGXIAN·Filed 2010·Granted Apr 15, 2014·5 cites·18 claims
- 1383US2023218587A1Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1482US9351964B2Methods for treating cancer and non-neoplastic conditionsALMSTEAD NEIL·Filed 2010·Granted May 31, 2016·6 cites·6 claims
- 1579US10285980B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2018·Granted May 14, 2019·1 cites·13 claims
- 1676US10675272B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2019·Granted Jun 9, 2020·0 cites·13 claims
- 1775US6395708B1Method for preventing diarrheaNOVARTIS AG·Filed 2000·Granted May 28, 2002·11 cites·2 claims
- 1874US9492449B2Therapies for hematologic malignanciesGALLATIN W MICHAEL·Filed 2012·Granted Nov 15, 2016·2 cites·16 claims
- 1974US2021038572A1Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2072US11497736B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·0 cites·13 claims
- 2169US10849885B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2018·Granted Dec 1, 2020·0 cites·10 claims
- 2268US2020368243A1Therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2020·Application pending·0 cites
- 2361US2019083498A1Therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2018·Application pending·0 cites
- 2459US10154998B2Therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2016·Granted Dec 18, 2018·0 cites·16 claims
- 2557US2005208146A1Novel dosage and administration method for oral camptosarPFIZER·Filed 2004·Application pending·0 cites
- 2648US2010158858A1Administration of carboline derivatives useful in the treatment of cancer and other diseasesCAO LIANGXIAN·Filed 2008·Application pending·0 cites
- 2746US2012129841A1Carboline derivatives useful in the treatment of cancer and other diseasesCAO LIANGXIAN·Filed 2011·Application pending·0 cites
- 2846US2017119771A1Combination therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2016·Application pending·0 cites
- 2945US2005267140A1Method for treating abnormal cell growthPFIZER·Filed 2005·Application pending·0 cites
- 3045US2022152214A1Cancer treatment with ror1 antibody immunoconjugatesVELOSBIO INC·Filed 2020·Application pending·0 cites
- 3144US2016199357A1Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewithPTC THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3243US2004258692A1Method for the treatment of cardiotoxicity induced by antitumor compoundsFiled 2002·Application pending·0 cites
- 3343US2013064812A1Combination therapies for hematologic malignanciesGALLATIN W MICHAEL·Filed 2012·Application pending·0 cites
- 3442US2012202801A1Methods for treating breast cancerCAO LIANGXIAN·Filed 2010·Application pending·0 cites
- 3542US2012157402A1Methods for treating brain tumorsCAO LIANGXIAN·Filed 2010·Application pending·0 cites
- 3642US2015196564A1Combination therapies for hematologic malignanciesGILEAD CALISTOGA LLC·Filed 2015·Application pending·0 cites
- 3741US2003096823A1Method for the treatment of cardiotoxicity induced by antitumor compoundsFiled 2001·Application pending·0 cites
- 3839US2004266704A1Method comprising irinotecan for treatment of breast cancerFiled 2004·Application pending·0 cites
- 3937US2011306622A1Methods of treating hematological disorders with quinazolinone compounds in selected subjectsLANNUTTI BRIAN·Filed 2011·Application pending·0 cites
- 4035US6159935AMethod for preventing diarrheaUPJOHN CO·Filed 1999·Granted Dec 12, 2000·2 cites·9 claims
- 4135US2012157401A1Methods for treating neurofibromatosisCAO LIANGXIAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Langdon Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →